Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Intangibles (2019 - 2025)

AVITA Medical (RCEL) has disclosed Intangibles for 3 consecutive years, with $5.8 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Intangibles rose 1084.8% year-over-year to $5.8 million, compared with a TTM value of $5.8 million through Dec 2024, up 1084.8%, and an annual FY2024 reading of $5.8 million, up 1084.8% over the prior year.
  • Intangibles was $5.8 million for Q4 2024 at AVITA Medical, up from $685000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $5.8 million in Q4 2024 and bottomed at $487000.0 in Q4 2023.
  • Average Intangibles over 3 years is $1.9 million, with a median of $621500.0 recorded in 2022.
  • The sharpest move saw Intangibles dropped 12.72% in 2023, then surged 1084.8% in 2024.
  • Year by year, Intangibles stood at $558000.0 in 2022, then decreased by 12.72% to $487000.0 in 2023, then soared by 1084.8% to $5.8 million in 2024.
  • Business Quant data shows Intangibles for RCEL at $5.8 million in Q4 2024, $685000.0 in Q2 2024, and $487000.0 in Q4 2023.